Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites

Hepatology

Volumn 53, Issue 3, 2011, Pages 1068-1069

  Lo, Gin Ho ^a  

^a I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; SODIUM;

ALBUMIN BLOOD LEVEL; ARTERIAL PRESSURE; ASCITES; BILIRUBIN BLOOD LEVEL; DRUG EFFECT; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; REFRACTORY ASCITES; SODIUM BLOOD LEVEL; SURVIVAL; VARIX BLEEDING;

ADRENERGIC BETA-ANTAGONISTS; ASCITES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; PROPRANOLOL; TREATMENT OUTCOME;

EID: 79952217609     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23986     Document Type: Letter

References (6)

1. Serste T, Melot C, Durand F, Rautou PE, Valla D, Moreau R, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. HEPATOLOGY 2010; 52: 1017-1022.
2. Wong F, Salerno F. Beta-blockers in cirrhosis: friend and foe? HEPATOLOGY 2010; 52: 811-813.
3. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. HEPATOLOGY 2009; 49: 2087-2107.
4. Lo GH. The management of cirrhotic ascites. HEPATOLOGY 2009; 50: 1320.
5. Lebrec D, Poynard T, Hillon P, Benhamou J-P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl Med 1981; 305: 1371-1374.
6. Lo GH, Chen WC, Lin CK, Tsai WL, Chan HH, Chen TA. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. HEPATOLOGY 2008; 48: 580-587.